|
1
|
Product specific BE guideline |
Edoxaban Tosylate Tablet-學名藥生體相等性試驗指導原則
|
2025-11-05 |
|
2
|
Product specific BE guideline |
Cholestyramine Powder-學名藥生體相等性試驗指導原則
|
2025-11-05 |
|
3
|
Product specific BE guideline |
Raloxifene Tablets_學名藥生體相等性試驗指導原則
|
2025-01-20 |
|
4
|
Product specific BE guideline |
Vigabatrin Tablets-學名藥生體相等性試驗指導原則
|
2023-10-01 |
|
5
|
Product specific BE guideline |
Lidocaine Patch-學名藥生體相等性試驗指導原則
|
2022-12-28 |
|
6
|
Product specific BE guideline |
Drospirenone/Ethinyl Estradiol Tablets-學名藥生體相等性試驗指導原則
|
2022-12-28 |
|
7
|
Product specific BE guideline |
Sorafenib Tosylate Tablets-學名藥生體相等性試驗指導原則
|
2022-12-28 |
|
8
|
Product specific BE guideline |
Sunitinib Hard Capsules-學名藥生體相等性試驗指導原則
|
2022-12-28 |
|
9
|
Product specific BE guideline |
Temozolomide Capsules-學名藥生體相等性試驗指導原則
|
2022-12-28 |
|
10
|
Product specific BE guideline |
Ticagrelor Tablets-學名藥生體相等性試驗指導原則
|
2022-12-28 |
